Alcon Inc. (ALC): Price and Financial Metrics


Alcon Inc. (ALC): $78.02

-0.95 (-1.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ALC POWR Grades


  • Growth is the dimension where ALC ranks best; there it ranks ahead of 99.24% of US stocks.
  • ALC's strongest trending metric is Growth; it's been moving up over the last 51 weeks.
  • ALC ranks lowest in Momentum; there it ranks in the 38th percentile.

ALC Stock Summary

  • ALC has a higher market value than 92.84% of US stocks; more precisely, its current market capitalization is $38,695,300,000.
  • ALC's went public 2.52 years ago, making it older than only 6.02% of listed US stocks we're tracking.
  • ALC's current price/earnings ratio is 211.45, which is higher than 96.82% of US stocks with positive earnings.
  • If you're looking for stocks that are quantitatively similar to Alcon Inc, a group of peers worth examining would be CSGP, BAX, A, IDXX, and PKI.
  • Visit ALC's SEC page to see the company's official filings. To visit the company's web site, go to www.alcon.com.

ALC Valuation Summary

  • In comparison to the median Healthcare stock, ALC's price/sales ratio is 36.84% higher, now standing at 5.2.
  • ALC's price/sales ratio has moved up 1.2 over the prior 29 months.
  • Over the past 29 months, ALC's price/sales ratio has gone up 1.2.

Below are key valuation metrics over time for ALC.

Stock Date P/S P/B P/E EV/EBIT
ALC 2021-08-31 5.2 2.1 220.8 121.0
ALC 2021-08-30 5.1 2.1 219.5 120.3
ALC 2021-08-27 5.1 2.1 219.7 120.4
ALC 2021-08-26 5.1 2.1 217.5 119.3
ALC 2021-08-25 5.1 2.1 216.4 118.7
ALC 2021-08-24 5.1 2.1 217.4 119.3

ALC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ALC has a Quality Grade of C, ranking ahead of 42.42% of graded US stocks.
  • ALC's asset turnover comes in at 0.284 -- ranking 134th of 185 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows ALC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.284 0.508 0.035
2021-03-31 0.252 0.448 -0.033
2020-12-31 0.249 0.430 -0.052
2020-09-30 0.248 0.438 -0.075
2020-06-30 0.249 0.451 -0.065
2020-03-31 0.273 0.489 -0.023

ALC Stock Price Chart Interactive Chart >

Price chart for ALC

ALC Price/Volume Stats

Current price $78.02 52-week high $87.49
Prev. close $78.97 52-week low $55.87
Day low $77.83 Volume 808,800
Day high $78.67 Avg. volume 854,847
50-day MA $80.30 Dividend yield N/A
200-day MA $73.31 Market Cap 38.09B

Alcon Inc. (ALC) Company Bio


Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.


ALC Latest News Stream


Event/Time News Detail
Loading, please wait...

ALC Latest Social Stream


Loading social stream, please wait...

View Full ALC Social Stream

Latest ALC News From Around the Web

Below are the latest news stories about Alcon Inc that investors may wish to consider to help them evaluate ALC as an investment opportunity.

Unusual Options Activity in Alcon (ALC), Nikola (NKLA), and NuVasive (NUVA)

We saw unusual or noteworthy options trading volume and activity in these three companies

iShook Finance | October 15, 2021

Alcon launches presbyopia correcting lens implant for patients undergoing cataract surgery

Approved by the Central Drug Standard Control Organization (CDSCO), Vivity is the first and only non-diffractive presbyopia-correcting intraocular lens (IOL) with minimum visual disturbance profile.

The Financial Express | October 14, 2021

Alcon Inc. Corporate: Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

Alcon associates across 43 global sites take the Steps for Sight challenge, raising funds to support organizations improving access to quality eye care Alcon Geneva associates will dedicate the da

FinanzNachrichten | October 14, 2021

Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

GENEVA, October 14, 2021--Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

Yahoo | October 14, 2021

Ophthalmology Cataract Surgery Devices Market Size, Key Players, Economic Impact and Forecast to 2027 | Abbott Laboratories, Alcon, Allergan

Market Summary A newly published report titled Ophthalmology Cataract Surgery Devices Market by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The report also highlights the

OpenPR | October 13, 2021

Read More 'ALC' Stories Here

ALC Price Returns

1-mo -7.49%
3-mo 12.84%
6-mo 3.78%
1-year 26.23%
3-year N/A
5-year N/A
YTD 18.25%
2020 16.63%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.97 seconds.